Coenzyme A as a central player in cellular and tissue homeostasis
PhD ceremony: Ms. K.A. Siudeja, 12.45 uur, Aula Academiegebouw, Broerstraat 5, Groningen
Dissertation: Coenzyme A as a central player in cellular and tissue homeostasis
Promotor(s): prof. O.C.M. Sibon
Faculty: Medical Sciences
Coenzyme A (CoA) is an important metabolite present in almost all living organisms. It is estimated that CoA acts as a cofactor in 4 % of all known enzymatic reactions. Although the involvement of CoA in these numerous reactions is well known, the consequences of impaired CoA metabolism have not been studied in detail. At the same time, it is known that in humans mutations in pantothenate kinase (PANK), the first enzyme in the CoA de novo biosynthesis pathway, cause the severe neurodegenerative disease PKAN (pantothenate kinase-associated neurodegeneration). The pathology of PKAN is complex and poorly understood, and no cure exists for this disease.
In this thesis we used different techniques and strategies to address the consequences of impaired CoA metabolism on the cellular and the whole-organism level. We used genetic and biochemical techniques to interfere with PANK activity in Drosophila melanogaster and human cell culture models of PKAN. We showed that the consequences of impaired CoA synthesis are far-reaching and involve many processes, which until now have not been directly linked to CoA metabolism. We address the involvement of CoA metabolism in the progression through the cell cycle, in posttranslational modification of proteins by acetylation of lysine residues or in the dynamic regulation of the actin cytoskeleton.
Altogether the results presented here not only contribute to increased fundamental cell biology knowledge, but may also serve for a better understanding of the pathophysiology of PKAN and suggest possible directions for the development of future PKAN therapies.
Last modified: | 13 March 2020 01.03 a.m. |
More news
-
27 August 2024
UMCG gaat onderzoeksfaciliteiten beschikbaar stellen voor geneesmiddelenontwikkeling
Om de beschikbaarheid en effectiviteit van geneesmiddelen in Nederland te verbeteren gaat het UMCG het bedrijf G² Solutions opzetten. Dit bedrijf moet ervoor gaan zorgen dat belangrijke technologische ontwikkelingen op het gebied van DNA sequencing...
-
17 July 2024
Veni-grants for ten researchers
The Dutch Research Council (NWO) has awarded a Veni grant of up to €320,000 each to ten researchers of the University of Groningen and the UMCG. The Veni grants are designed for outstanding researchers who have recently gained a PhD.
-
16 July 2024
Medicine still subjects to male bias
Aranka Ballering studied the course of illness in people with common symptoms. One of the most striking findings to emerge from her research was that on average, women have a different – and less extensive – course of illness than men.